Catalysis with Gold Complexes on Carbon Nanotubes
FULL PAPER
General procedure for cyclisation of enynes 8 and 12–16 catalysed by the
AuI complex 6: The enyne (9.63ꢂ10À2 mmol) in CH2Cl2 (3 mL) was
added to gold catalyst 6 (2 mg, 1.925ꢂ10À3 mmol, 2 mol%) in CH2Cl2
(2 mL) and the mixture was stirred at room temperature for the duration
indicated in Scheme 4. The resulting mixture was filtered through SiO2
and the solvent evaporated to give the corresponding product (9–11, 18–
24; see the Supporting Information). These compounds have been report-
ed in the literature previously: 9,[69] 10,[66] 11,[70] 18,[34] 19,[34] 20,[34] 21,[34]
22,[34] 23,[71] 24.[71]
Experimental Section
General methods: Unless otherwise stated, all the manipulations were
carried out under an atmosphere of argon by using standard Schlenk
techniques and with anhydrous solvents. Hexane, diethyl ether and tetra-
hydrofuran were distilled from sodium benzophenone under argon. Di-
chloromethane and acetonitrile were distilled from CaH2. Anhydrous
acetone was used as received (Fisher chemical). MWNTs were obtained
from Nanocyl (Thin MWCNT, 95+% C purity). NMR spectra were re-
corded on Bruker spectrometers (more details can be found in the Sup-
porting Information), HRMS were recorded on a Q-Extractive orbitrap
spectrometer from ThermoFisher and XPS analyses were carried out
with a SSI-X-probe (SSX 100/206) photoelectron spectrometer from Sur-
face Science Instruments (more details can be found in the Supporting
Information). ICP analyses were realised by MEDAC Ltd. (U.K.). The
following compounds were obtained according to literature procedures:
8,[66] 12,[34] 13,[66] 14,[67] 15,[34]16[68] and 17.[68]
General procedure for the cyclisation of enynes 8 and 12–17 catalysed by
the AuI complex 6: f-MWNTs 7 (3.55ꢂ10À3 mmol, 2 mol% of supported
gold complex based on ICP values, typically 20 mg) were submitted to ul-
trasound in CH2Cl2 (4 mL) for 10 min. The enyne (0.178 mmol) in
CH2Cl2 (3 mL) was then added and the mixture stirred for 30 min (8, 12–
16) or 7 h (17). Agitation was then stopped and the solution was cooled
to À408C (bath CH3CN/N2) for 30 min. The reaction products were sepa-
rated from system 7 by centrifugation (6500 rpm, 5 min). The products
1
were filtered through Celite and analysed by H NMR spectroscopy.
Synthesis of the bifunctional ligand 4: The first two steps, that is, com-
pounds 2 and 3, have been described previously.[64] 1-Pyrenebutyric acid
(1.54 g, 5.35 mmol), dimethylaminopyridine (DMAP; 160 mg, 1.34 mmol)
and N,N’-dicyclohexylcarbodiimide (DCC; 1.01 g, 4.91 mmol) were added
to a solution of 4-diphenylphosphanylbenzylamine (3; 1,3 g, 4.46 mmol)
in CH2Cl2 (40 mL). The resulting mixture was stirred at room tempera-
ture overnight. After extractive workup (1m HCl, H2O, 1 m NaOH, H2O),
the resulting organic phases were dried with MgSO4 and thereafter puri-
fied by chromatography (95:5 CH2Cl2/AcOEt) to obtain 4 (2.18 g, 87%)
as a pale-yellow solid. 1H NMR (300 MHz, CDCl3): d=8.28 (d, J=
9.3 Hz, 1H), 8.20–7.94 (m, 7H), 7.83 (d, J=7.8 Hz, 1H), 7.38–7.18 (m,
14H), 5.64 (s, 1H), 4.43 (d, J=5.7 Hz, 2H), 3.40 (t, J=7.1 Hz, 2H), 2.36–
2.17 ppm (m, 4H); 13C NMR (75 MHz, CDCl3): d=172.60, 138.91,
136.69, 135.62, 134.16, 133.90, 133.73, 133.48, 131.29, 130.77, 129.83,
128.80, 128.53, 128.44, 127.85, 127.75, 127.38, 127.33, 127.26, 126.65,
125.79, 124.86, 124.72, 123.25, 43.19, 35.69, 32.57, 27.30 ppm; 31P NMR
(121 MHz, CDCl3): d=À5.32 ppm; HRMS (ESI): m/z calcd for
C39H33O1N1P1: 562.22943 [M+1]+; found: 562.22876.
General procedure for the recycling of catalyst 7—cyclisation of enyne 8
and 14: The procedure was carried out in accordance with Scheme 5. f-
MWNTs 7 (3.55ꢂ10À3 mmol, 2 mol% of supported gold complex based
on ICP values) were submitted to ultrasound in CH2Cl2 (4 mL) for
10 min. Enyne 8 (42 mg, 0.178 mmol) or enyne 14 (49 mg, 0.178 mmol) in
CH2Cl2 (3 mL) was added and the mixture was stirred for 30 min. Agita-
tion was then stopped and the solution cooled to À408C (bath CH3CN/
N2) for 30 min. The mixture was submitted to centrifugation (6500 rpm,
5 min) and washed with cold CH2Cl2 (À408C, 5 mL, 6500 rpm, 5 min) to
separate the reaction products from the catalyst 7. The products were fil-
tered through Celite (except when leaching was analysed) and analysed
1
by H NMR spectroscopy. The f-MWNTs were vacuum-dried and used in
the subsequent catalytic cycles following the protocol described above.
Acknowledgements
We acknowledge the FRS-FNRS, FRIA, Fꢁdꢁration Wallonie-Bruxelles,
Loterie Nationale, the Belgian State (IAP Project No. P6/17) and the
Universitꢁ catholique de Louvain for funding. We are also grateful to
Nanocyl for supplying MWNTs, and to T. Haynes and J.-F. Statsijns for
technical support.
Synthesis of the gold complex 6: The bifunctional ligand 4 (112 mg,
0.2 mmol) was added to a solution of ClAuSMe2 (59 mg, 0.2 mmol) in
CH2Cl2 (10 mL). The resulting mixture was stirred at room temperature
for 20 min, the solvent was removed under reduced pressure and the resi-
due vacuum-dried to obtain the gold complex 5 as a pale-yellow solid.
Complex
5 was dissolved in CH2Cl2 (10 mL) and AgNTf2 (78 mg,
0.2 mmol) was added. The mixture was stirred at room temperature for
20 min, then filtered through a millipore membrane in a disposable plas-
tic syringe and the solution concentrated by removing most of the solvent
on a Schlenk line. Hexane was added (20 mL) to induce the precipitation
of 6 (176 mg, 85%) as a pale-yellow solid: 1H NMR (300 MHz, CDCl3):
d=8.32–7.75 (m, 9H), 7.61–7.36 (m, 14H), 5.81 (s, 1H), 4.46 (d, J=
5.8 Hz, 2H), 3.40 (t, J=7.2 Hz, 2H), 2.39–2.16 ppm (m, 4H); 13C NMR
(126 MHz, CDCl3): d=175.73, 142.70, 135.27, 134.33, 134.22, 133.99,
133.88, 132.80, 131.35, 130.78, 129.99, 129.72, 129.62, 128.83, 128.73,
128.64, 127.50, 127.40, 127.00, 126.86, 126.47, 126.02, 125.59, 125.09,
125.00, 124.88, 123.15, 121.00, 118.44, 43.36, 35.70, 32.63, 27.89 ppm;
[9] P. Singh, S. Campidelli, S. Giordani, D. Bonifazi, A. Bianco, M.
[14] C. Schulz-Drost, V. Sgobba, C. Gerhards, S. Leubner, R. M. Krieck
31P NMR (121 MHz, CDCl3): d=30.05 ppm; 19F NMR (282 MHz,
CDCl3): d=À75.44; HRMS (ESI): m/z calcd for C39H32O1N1197Au1P1
:
+
758.18815;
found
758.18809;
MS
(ESI)
m/z
calcd
for
C2O4N1F632S2À:279.91674; found 279.91830.
General procedure for the immobilisation of the gold complex 6 onto
MWNTs to obtain 7: Thin MWCNTs (95+% purity; 100 mg,
C
8.33 mmol) were submitted to ultrasound for 1 h in the selected solvent
(acetone, dichloromethane or acetonitrile; 30 mL). The pyrene-tagged
gold(I) complex 6 was then added (100 mg, 0.1 mmol) and the resulting
mixture was stirred at room temperature for various times (from 20 min
to 1 day). The resulting powder was submitted to centrifugation
(6500 rpm, 5 min) and washed twice with the selected solvent (6500 rpm,
5 min) to separate the non-immobilised gold complex 6 from the sup-
ported homogeneous catalyst system 7. The resulting supported homoge-
neous catalyst was vacuum-dried.
Chem. Eur. J. 2013, 00, 0 – 0
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
9
&
ÞÞ
These are not the final page numbers!